NRAS and Miyoshi myopathy: Also, in this area, 85 MM patients treated with anti-PD-1 monotherapy were followed for almost two years by determining BRAF V600E/K or NRAS Q61/G12/G13 in ctDNA (copies/mL plasma) [98].